Works matching IS 03407004 AND DT 2010 AND VI 59 AND IP 5

Results: 16

Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 799, doi. 10.1007/s00262-009-0806-4

By:

Trimble, Cornelia L.;
Peng, Shiwen;
Thoburn, Christopher;
Kos, Ferdynand;
Wu, T. C.

Publication type:

Article

Activation of innate immunity to reduce lung metastases in breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 789, doi. 10.1007/s00262-009-0800-x

By:

Jordan, Julie L.;
Nowak, A.;
Lee, T. D. G.

Publication type:

Article

Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 779, doi. 10.1007/s00262-009-0798-0

By:

You, Chang-Xuan;
Liu, Yong;
Shi, Min;
Cao, Maohua;
Luo, Rong-Cheng;
Hermonat, Paul L.

Publication type:

Article

Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 769, doi. 10.1007/s00262-009-0797-1

By:

Tongu, Miki;
Harashima, Nanae;
Yamada, Takaya;
Harada, Takayuki;
Harada, Mamoru

Publication type:

Article

Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 737, doi. 10.1007/s00262-009-0794-4

By:

Sarnovsky, Robert;
Tendler, Tara;
Makowski, Matheusz;
Kiley, Maureen;
Antignani, Antonella;
Traini, Roberta;
Zhang, Jingli;
Hassan, Raffit;
FitzGerald, David J.

Publication type:

Article

Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 687, doi. 10.1007/s00262-009-0784-6

By:

May, Matthias;
Brookman-May, Sabine;
Hoschke, Bernd;
Gilfrich, Christian;
Kendel, Friederike;
Baxmann, Susann;
Wittke, Stefan;
Kiessig, Stephan T.;
Miller, Kurt;
Johannsen, Manfred

Publication type:

Article

Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 675, doi. 10.1007/s00262-009-0783-7

By:

Yamasaki, Akio;
Kameda, Chizu;
Xu, Rui;
Tanaka, Haruo;
Tasaka, Takehiko;
Chikazawa, Nobuhito;
Suzuki, Hiroyuki;
Morisaki, Takashi;
Kubo, Makoto;
Onishi, Hideya;
Tanaka, Masao;
Katano, Mitsuo

Publication type:

Article

Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 653, doi. 10.1007/s00262-009-0781-9

By:

Suzuki, Hiroyuki;
Chikazawa, Nobuhito;
Tasaka, Takehiko;
Wada, Junji;
Yamasaki, Akio;
Kitaura, Yoshiki;
Sozaki, Masae;
Tanaka, Masao;
Onishi, Hideya;
Morisaki, Takashi;
Katano, Mitsuo

Publication type:

Article

Immunologic and Prognostic Factors Associated with Overall Survival Employing a Poxviral-based PSA Vaccine in Metastatic Castrate-resistant Prostate Cancer.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 1, doi. 10.1007/s00262-009-0782-8

By:

Gulley, James L.;
Arlen, Philip M.;
Madan, Ravi A.;
Kwong-Yok Tsang;
Pazdur, Mary P.;
Skarupa, Lisa;
Jones, Jacquin L.;
Poole, Diane J.;
Higgins, Jack P.;
Hodge, James W.;
Cereda, Vittore;
Vergati, Matteo;
Steinberg, Seth M.;
Halabi, Susan;
Jones, Elizabeth;
Chen, Clara;
Parnes, Howard;
Wright, John J.;
Dahut, William L.;
Schlom, Jeffrey

Publication type:

Article

Testing the theory of immune selection in cancers that break the rules of transplantation.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 643, doi. 10.1007/s00262-009-0809-1

By:

Fassati, Ariberto;
Mitchison, N. Avrion

Publication type:

Article

EphA2-derived peptide vaccine with amphiphilic poly(γ-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 759, doi. 10.1007/s00262-009-0796-2

By:

Yamaguchi, Shinjiro;
Tatsumi, Tomohide;
Takehara, Tetsuo;
Sasakawa, Akira;
Yamamoto, Masashi;
Kohga, Keisuke;
Miyagi, Takuya;
Kanto, Tatsuya;
Hiramastu, Naoki;
Akagi, Takami;
Akashi, Mitsuru;
Hayashi, Norio

Publication type:

Article

Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2′-deoxycytidine.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 697, doi. 10.1007/s00262-009-0786-4

By:

Daurkin, Irina;
Eruslanov, Evgeniy;
Vieweg, Johannes;
Kusmartsev, Sergei

Publication type:

Article

Identification and characterization of a HER-2/ neu epitope as a potential target for cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 715, doi. 10.1007/s00262-009-0791-7

By:

Lekka, Eftychia;
Gritzapis, Angelos D.;
Perez, Sonia A.;
Tsavaris, Nikolaos;
Missitzis, Ioannis;
Mamalaki, Avgi;
Papamichail, Michael;
Baxevanis, Constantin N.

Publication type:

Article

A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 707, doi. 10.1007/s00262-009-0790-8

By:

Weijun Zhang;
Tong Zhang;
Turk, Mary-Jo;
Usherwood, Edward J.

Publication type:

Article

TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 729, doi. 10.1007/s00262-009-0793-5

By:

Vohra, Nasreen;
Verhaegen, Monique;
Martin, Lisa;
Mackay, Amy;
Pilon-Thomas, Shari

Publication type:

Article

Topoisomerase II alpha as a universal tumor antigen: antitumor immunity in murine tumor models and H-2Kb-restricted T cell epitope.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 747, doi. 10.1007/s00262-009-0795-3

By:

Jung-Sun Park;
Hye-Sung Kim;
Mi-Young Park;
Chang-Hyun Kim;
Yeun-Jun Chung;
Yong-Kil Hong;
Tai-Gyu Kim

Publication type:

Article

Works matching IS 03407004 AND DT 2010 AND VI 59 AND IP 5

Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3.

Activation of innate immunity to reduce lung metastases in breast cancer.

Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function.

Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma.

Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin.

Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting.

Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh.

Intratumoral CD8<sup>+</sup> T/FOXP3<sup>+</sup> cell ratio is a predictive marker for survival in patients with colorectal cancer.

Immunologic and Prognostic Factors Associated with Overall Survival Employing a Poxviral-based PSA Vaccine in Metastatic Castrate-resistant Prostate Cancer.

Testing the theory of immune selection in cancers that break the rules of transplantation.

EphA2-derived peptide vaccine with amphiphilic poly(γ-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor.

Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2′-deoxycytidine.

Identification and characterization of a HER-2/ neu epitope as a potential target for cancer immunotherapy.

A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector.

TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model.

Topoisomerase II alpha as a universal tumor antigen: antitumor immunity in murine tumor models and H-2K<sup>b</sup>-restricted T cell epitope.